"Our events have grown with this market organically. Especially over the past five years, we have seen India become the fourth largest pharma market globally and it is exciting to see the progress," noted Greg Kerwin, UBM Pharma Portfolio Director. He continued, "We are pleased to see that our customer base continues to grow and has positive feedback about the impact that the India pharma events have on their business. We work very hard to ensure that the events facilitate maximum exposure across the various sectors of the Indian Pharma market."
New exhibitor, Technoflex, confirmed that they saw immediate results from the event. Sylvie Ponlot, Communication Manager for the company commented, "This was our first CPhI India in Mumbai. We made contact with many new prospective clients and several customers. We strongly believe that new projects will result from our attendance. This was a really fruitful show for Technoflex and we will definitely be in Mumbai next year."
CPhI India, ICSE and P-MEC India will return to the Bombay Exhibition Centre in Mumbai from 21-23 November 2012. To learn more about CPhI India, please visit: http://www.cphi-india.com/home
UBM's market leading schedule of annual pharma events also includes Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Centre, Japan), South East Asia (10-12 May, 2012, Jakarta International Expo, Indonesia), ICSE USA (22-23 May, 2012, Pennsylvania Convention Centre, Philadelphia), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).
Notes for Editors:
UBM Live is a division of UBM Plc (LSE:
|SOURCE UBM Live|
Copyright©2010 PR Newswire.
All rights reserved